Cargando…

Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?

The underline hypothesis of this study was that SARS-CoV-2 can infect individuals regardless of health condition, sex, and age in opposition to the classical epidemiological assumption of an identifiable susceptible subpopulation for epidemic development. To address this issue, a population cohort w...

Descripción completa

Detalles Bibliográficos
Autores principales: Acevedo-Sánchez, Gerardo, Mora-Aguilera, Gustavo, Coria-Contreras, Juan J., Álvarez-Maya, Ikuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441236/
https://www.ncbi.nlm.nih.gov/pubmed/37608984
http://dx.doi.org/10.3389/fpubh.2023.995602
_version_ 1785093339750596608
author Acevedo-Sánchez, Gerardo
Mora-Aguilera, Gustavo
Coria-Contreras, Juan J.
Álvarez-Maya, Ikuri
author_facet Acevedo-Sánchez, Gerardo
Mora-Aguilera, Gustavo
Coria-Contreras, Juan J.
Álvarez-Maya, Ikuri
author_sort Acevedo-Sánchez, Gerardo
collection PubMed
description The underline hypothesis of this study was that SARS-CoV-2 can infect individuals regardless of health condition, sex, and age in opposition to the classical epidemiological assumption of an identifiable susceptible subpopulation for epidemic development. To address this issue, a population cohort with 24.4 million metadata associated with 226,089 official RT-qPCR positive and 283,450 negative cases, including 27,769 deceased, linked putatively to B.1. and B.1.1. SARS-CoV-2 lineages were analyzed. The analysis baseline was to determine the infection and mortality structure of the diseased cohort at the onset-exponential phase of the first epidemic wave in Mexico under the assumption of limited herd immunity. Individuals with nonchronic diseases (NOCDs) were compared with those exhibiting at least one of 10 chronic diseases (CDs) adjusted by age and sex. Risk factors for infection and mortality were estimated with classification and regression tree (CART) and cluster analysis based on Spearman's matrix of rho-values in RStudio(®), complemented with two proposed mortality indices. SARS-CoV-2 infection was independent of health condition (52.8% NOCD vs. 47.2% CDs; p = 0.001–0.009) but influenced by age >46 in one risk analysis scenario (p < 0.001). Sex contributed 9.7% to the overall risk. The independent effect was supported by the health structure of negative cases with a similar tendency but a higher proportion of NOCDs (61.4%, p = 0.007). The infection probability in individuals with one CD was determined by the disease type and age, which was higher in those older individuals (≥56 years) exhibiting diabetes (12.3%, cp = 0.0006), hypertension (10.1%, cp < 0.0001), and obesity (7.8%, cp = 0.001). In contrast, the mortality risk was heavily influenced by CD conditioned by sex and age, accounting for 72.3% of total deaths (p = 0.001–0.008). Significant mortality risk (48%) was comprised of women and men (w, m) aged ≥56 years with diabetes (19% w and 27.9% m, cp < 0.0004), hypertension (11.5% w, cp = 0.0001), and CKD (3.5% w and 5.3% m, cp = 0.0009). Older people with diabetes and hypertension comorbidity increased the risk to 60.5% (p = 0.001). Based on a mortality-weighted index, women were more vulnerable to preexisting metabolic or cardiovascular diseases. These findings support our hypothesis and justify the need for surveillance systems at a communitarian level. This is the first study addressing this fundamental epidemiological question.
format Online
Article
Text
id pubmed-10441236
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104412362023-08-22 Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico? Acevedo-Sánchez, Gerardo Mora-Aguilera, Gustavo Coria-Contreras, Juan J. Álvarez-Maya, Ikuri Front Public Health Public Health The underline hypothesis of this study was that SARS-CoV-2 can infect individuals regardless of health condition, sex, and age in opposition to the classical epidemiological assumption of an identifiable susceptible subpopulation for epidemic development. To address this issue, a population cohort with 24.4 million metadata associated with 226,089 official RT-qPCR positive and 283,450 negative cases, including 27,769 deceased, linked putatively to B.1. and B.1.1. SARS-CoV-2 lineages were analyzed. The analysis baseline was to determine the infection and mortality structure of the diseased cohort at the onset-exponential phase of the first epidemic wave in Mexico under the assumption of limited herd immunity. Individuals with nonchronic diseases (NOCDs) were compared with those exhibiting at least one of 10 chronic diseases (CDs) adjusted by age and sex. Risk factors for infection and mortality were estimated with classification and regression tree (CART) and cluster analysis based on Spearman's matrix of rho-values in RStudio(®), complemented with two proposed mortality indices. SARS-CoV-2 infection was independent of health condition (52.8% NOCD vs. 47.2% CDs; p = 0.001–0.009) but influenced by age >46 in one risk analysis scenario (p < 0.001). Sex contributed 9.7% to the overall risk. The independent effect was supported by the health structure of negative cases with a similar tendency but a higher proportion of NOCDs (61.4%, p = 0.007). The infection probability in individuals with one CD was determined by the disease type and age, which was higher in those older individuals (≥56 years) exhibiting diabetes (12.3%, cp = 0.0006), hypertension (10.1%, cp < 0.0001), and obesity (7.8%, cp = 0.001). In contrast, the mortality risk was heavily influenced by CD conditioned by sex and age, accounting for 72.3% of total deaths (p = 0.001–0.008). Significant mortality risk (48%) was comprised of women and men (w, m) aged ≥56 years with diabetes (19% w and 27.9% m, cp < 0.0004), hypertension (11.5% w, cp = 0.0001), and CKD (3.5% w and 5.3% m, cp = 0.0009). Older people with diabetes and hypertension comorbidity increased the risk to 60.5% (p = 0.001). Based on a mortality-weighted index, women were more vulnerable to preexisting metabolic or cardiovascular diseases. These findings support our hypothesis and justify the need for surveillance systems at a communitarian level. This is the first study addressing this fundamental epidemiological question. Frontiers Media S.A. 2023-08-07 /pmc/articles/PMC10441236/ /pubmed/37608984 http://dx.doi.org/10.3389/fpubh.2023.995602 Text en Copyright © 2023 Acevedo-Sánchez, Mora-Aguilera, Coria-Contreras and Álvarez-Maya. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Acevedo-Sánchez, Gerardo
Mora-Aguilera, Gustavo
Coria-Contreras, Juan J.
Álvarez-Maya, Ikuri
Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?
title Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?
title_full Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?
title_fullStr Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?
title_full_unstemmed Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?
title_short Were metabolic and other chronic diseases the driven onset epidemic forces of COVID-19 in Mexico?
title_sort were metabolic and other chronic diseases the driven onset epidemic forces of covid-19 in mexico?
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441236/
https://www.ncbi.nlm.nih.gov/pubmed/37608984
http://dx.doi.org/10.3389/fpubh.2023.995602
work_keys_str_mv AT acevedosanchezgerardo weremetabolicandotherchronicdiseasesthedrivenonsetepidemicforcesofcovid19inmexico
AT moraaguileragustavo weremetabolicandotherchronicdiseasesthedrivenonsetepidemicforcesofcovid19inmexico
AT coriacontrerasjuanj weremetabolicandotherchronicdiseasesthedrivenonsetepidemicforcesofcovid19inmexico
AT alvarezmayaikuri weremetabolicandotherchronicdiseasesthedrivenonsetepidemicforcesofcovid19inmexico